- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
CA.3: 7 residues within 4Å:- Chain A: A.867, S.870, R.871, D.872, S.874, S.907, N.908
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:A.867, A:S.870, A:S.874, A:S.907, A:N.908
CA.9: 5 residues within 4Å:- Chain A: H.741, Y.743, D.832, T.836, G.837
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.741, A:Y.743, A:T.836, A:G.837, H2O.38
CA.12: 7 residues within 4Å:- Chain B: A.867, S.870, R.871, D.872, S.874, S.907, N.908
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:A.867, B:S.870, B:S.874, B:S.907, B:N.908
CA.19: 5 residues within 4Å:- Chain B: H.741, Y.743, D.832, T.836, G.837
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.741, B:Y.743, B:T.836, B:G.837, H2O.73
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.4: 32 residues within 4Å:- Chain A: E.45, G.46, G.47, L.74, K.256, L.257, V.258, V.259, G.260, N.261, T.262, E.263, I.264, L.287, A.301, W.336, F.337, A.338, V.342, A.346, S.347, G.350, N.351, I.353, T.354, S.359, D.360, I.403, L.404, K.422, D.429, D.430
28 PLIP interactions:28 interactions with chain A- Hydrophobic interactions: A:L.74, A:A.338, A:V.342
- Hydrogen bonds: A:L.257, A:L.257, A:V.259, A:G.260, A:N.261, A:T.262, A:T.262, A:E.263, A:I.264, A:A.338, A:S.347, A:N.351, A:T.354, A:T.354, A:D.360, A:D.360, A:D.360, A:L.404, A:L.404, A:K.422
- Water bridges: A:K.256, A:K.256, A:S.347, A:A.432
- pi-Stacking: A:F.337
FAD.13: 30 residues within 4Å:- Chain B: E.45, G.46, G.47, L.74, K.256, L.257, V.258, V.259, G.260, N.261, T.262, E.263, I.264, A.301, F.337, A.338, V.342, A.346, S.347, G.350, N.351, I.353, T.354, S.359, D.360, I.403, L.404, K.422, D.429, D.430
24 PLIP interactions:24 interactions with chain B- Hydrophobic interactions: B:L.74, B:A.338, B:V.342
- Hydrogen bonds: B:L.257, B:L.257, B:V.259, B:G.260, B:N.261, B:T.262, B:E.263, B:I.264, B:A.338, B:V.345, B:S.347, B:N.351, B:T.354, B:T.354, B:D.360, B:D.360, B:L.404, B:L.404, B:K.422
- Water bridges: B:S.347
- pi-Stacking: B:F.337
- 2 x BCT: BICARBONATE ION(Non-functional Binders)
BCT.5: 9 residues within 4Å:- Chain A: R.839, H.840, I.877, T.909, A.910, F.911, F.914, G.915, Q.918
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:H.840, A:F.911, A:F.911
BCT.14: 9 residues within 4Å:- Chain B: R.839, H.840, I.877, T.909, A.910, F.911, F.914, G.915, Q.918
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:R.839, B:F.911, B:F.914, B:G.915, B:Q.918
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
MTE.6: 20 residues within 4Å:- Chain A: Q.112, C.150, G.796, G.797, F.798, G.799, R.912, M.1038, G.1039, Q.1040, A.1078, A.1079, S.1080, V.1081, S.1082, Q.1194, G.1260, E.1261
- Ligands: MOS.7, FYO.8
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:Q.112, A:G.797, A:F.798, A:R.912, A:M.1038, A:Q.1040, A:S.1082, A:S.1082, A:T.1083, A:Q.1194, A:Q.1194
- Water bridges: A:R.912
MTE.15: 20 residues within 4Å:- Chain B: Q.112, C.150, G.796, G.797, F.798, G.799, R.912, M.1038, G.1039, Q.1040, A.1078, A.1079, S.1080, V.1081, S.1082, Q.1194, G.1260, E.1261
- Ligands: MOS.16, FYO.17
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:Q.112, B:G.797, B:F.798, B:M.1038, B:Q.1040, B:S.1082, B:S.1082, B:S.1082, B:Q.1194, B:Q.1194, B:G.1260
- Water bridges: B:Q.112, B:R.912
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
MOS.7: 11 residues within 4Å:- Chain A: Q.767, F.798, G.799, E.802, A.910, F.911, R.912, A.1078, E.1261
- Ligands: MTE.6, FYO.8
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.767
MOS.16: 11 residues within 4Å:- Chain B: Q.767, G.799, E.802, A.910, F.911, R.912, T.1077, A.1078, E.1261
- Ligands: MTE.15, FYO.17
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.767, B:E.802
- 2 x FYO: 4-[5-(2,6-dioxo-1,2,3,6-tetrahydropyridin-4-yl)-1H-1,2,4-triazol-3-yl]-6-oxo-1,6-dihydropyridine-2-carbonitrile(Non-covalent)
FYO.8: 15 residues within 4Å:- Chain A: L.648, E.802, L.873, S.876, R.880, F.914, S.1008, F.1009, F.1013, L.1014, A.1078, A.1079, E.1261
- Ligands: MTE.6, MOS.7
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.648, A:L.873, A:F.1009, A:L.1014
- Hydrogen bonds: A:S.876, A:R.880, A:R.880, A:A.1079
- pi-Stacking: A:F.914
FYO.17: 16 residues within 4Å:- Chain B: L.648, K.771, E.802, L.873, S.876, R.880, F.914, S.1008, F.1009, V.1011, L.1014, A.1078, A.1079, E.1261
- Ligands: MTE.15, MOS.16
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:L.873, B:V.1011, B:L.1014
- Hydrogen bonds: B:R.880, B:A.1079
- Water bridges: B:S.876
- pi-Stacking: B:F.914, B:F.1009
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.18: 9 residues within 4Å:- Chain B: C.662, G.664, H.665, I.666, R.804, I.835, N.869, S.906, S.907
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:G.664, B:H.665, B:I.666, B:N.869, B:S.906, B:S.907
- Water bridges: B:R.804, B:R.804
GOL.20: 6 residues within 4Å:- Chain B: D.594, F.604, P.675, R.824, C.825, M.826
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:M.826
- Water bridges: B:M.826, B:D.828
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Matsumoto, K. et al., FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase. J.Pharmacol.Exp.Ther. (2011)
- Release Date
- 2010-11-03
- Peptides
- Xanthine dehydrogenase/oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x BCT: BICARBONATE ION(Non-functional Binders)
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
- 2 x FYO: 4-[5-(2,6-dioxo-1,2,3,6-tetrahydropyridin-4-yl)-1H-1,2,4-triazol-3-yl]-6-oxo-1,6-dihydropyridine-2-carbonitrile(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Matsumoto, K. et al., FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase. J.Pharmacol.Exp.Ther. (2011)
- Release Date
- 2010-11-03
- Peptides
- Xanthine dehydrogenase/oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B